Aurobindo Pharma Fact Sheet, Aurobindo Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aurobindo Pharma Fact Sheet    (AUBD)


Find Out: How to Create Massive Gains from Govt's Mega 2023 Plan?


Here is the latest financial fact sheet of Aurobindo Pharma. For more details, see the Aurobindo Pharma quarterly results and Aurobindo Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

AUROBINDO PHARMA Price History

Price Rs 702.0
Mkt Cap Rs m 411,329
Vol '000 408.6
P/E X 7.7
P/CF X 6.4
EPS (TTM) Rs 91.7
% ch % -1.6
No. of shares m 585.94
% ch week % -3.8
% ch 1-mth % -1.5
% ch 12-mth % -12.3
52 week H/L Rs 1,063.8/660.1
(As on Oct 20, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AUROBINDO PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
AUROBINDO PHARMA EQUITY SHARE DATA
High Rs8958098308381,023 
Low Rs622504527281333 
Sales per share (Unadj.) Rs251.4280.4333.9394.2422.8 
Earnings per share (Unadj.) Rs39.241.340.348.892.0 
Diluted earnings per shareRs39.241.340.348.892.0 
Cash flow per share (Unadj.) Rs46.550.851.765.3110.0 
Dividends per share (Unadj.) Rs2.502.502.503.004.00 
Adj. dividends per shareRs2.502.502.503.004.00 
Avg Dividend yield %0.30.40.40.50.6 
Book value per share (Unadj.) Rs160.0199.4237.1287.1374.3 
Adj. book value per shareRs159.9199.3237.1287.1374.3 
Shares outstanding (eoy) m585.88585.91585.89585.94585.94 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.02.32.01.41.6 
Avg P/E ratio x19.415.916.811.57.4 
P/CF ratio (eoy) x16.312.913.18.66.2 
Price / Book Value ratio x4.73.32.91.91.8 
Dividend payout %6.46.16.26.14.3 
Avg Mkt Cap Rs m444,392384,634397,541327,877397,398 
No. of employees `000NANANANANA 
Total wages/salary Rs m17,67821,30825,84932,19235,350 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
AUROBINDO PHARMA INCOME DATA
Net Sales Rs m147,292164,262195,636230,985247,746 
Other income Rs m1,1591,0201,5531,9193,809 
Total revenues Rs m148,451165,282197,189232,904251,555 
Gross profit Rs m34,34337,71838,63948,38281,480 
Depreciation Rs m4,2765,5806,6809,66710,554 
Interest Rs m6677772,6263,051745 
Profit before tax Rs m30,55832,38030,88737,58273,990 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7,5978,1837,2698,99420,098 
Profit after tax Rs m22,96224,19823,61828,58953,892 
Gross profit margin %23.323.019.820.932.9 
Effective tax rate %24.925.323.523.927.2 
Net profit margin %15.614.712.112.421.8 
AUROBINDO PHARMA BALANCE SHEET DATA
Current assets Rs m92,062121,782153,323164,125198,235 
Current liabilities Rs m66,05686,659120,206113,846106,652 
Net working cap to sales %17.721.416.921.837.0 
Current ratio x1.41.41.31.41.9 
Inventory Days Days1415151519 
Debtors Days Days6968646852 
Net fixed assets Rs m68,75587,641109,388123,520135,778 
Share capital Rs m586586586586586 
"Free" reserves Rs m93,132116,218138,321167,661218,713 
Net worth Rs m93,718116,804138,907168,247219,299 
Long term debt Rs m1,8144,5121,80001,684 
Total assets Rs m160,817209,422262,711287,645334,013 
Interest coverage x46.842.712.813.3100.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.80.70.80.7 
Return on assets %14.711.910.011.016.4 
Return on equity %24.520.717.017.024.6 
Return on capital %32.727.323.824.233.8 
Exports to sales %51.449.149.646.453.8 
Imports to sales %18.419.418.815.116.4 
Exports (fob) Rs m75,76180,68197,091107,126133,248 
Imports (cif) Rs m27,08931,85336,74134,90240,615 
Fx inflow Rs m75,83880,72797,316107,445133,248 
Fx outflow Rs m30,22434,70040,58938,99144,946 
Net fx Rs m45,61346,02756,72768,45488,302 
AUROBINDO PHARMA CASH FLOW
From Operations Rs m 32,786 19,545 16,510 43,813 33,289 
From Investments Rs m -17,870 -19,266 -29,026 -15,676 5,987 
From Financial Activity Rs m -19,153 8,642 19,191 -19,472 -13,648 
Net Cashflow Rs m -4,239 8,919 6,656 8,712 25,831 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.8%
Institution 37.2%
Non-Institution 10.9%
Total 100.0%
Free Float 48.2%
Pledged promoter holdings 23.0%
 

Company Information

REGD OFF Plot No. 2, Maitrivihar, Ameerpet, Hyderabad - 500038
E-MAIL info@aurobindo.com WEB www.aurobindo.com
TEL 040-23736370/23747340 FAX 040-23741080/23746833
SECTOR PHARMACEUTICALS GROUP Aurobindo
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
AUDITOR S. R. Batliboi & Assoc.
CHM: K. Ragunathan COMP SEC: A. Mohan Rami Reddy YEAR OF INC: 1986 BSE CODE: 524804 FV (Rs): 1 DIV YIELD (%): 0.6

Read: AUROBINDO PHARMA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ANUH PHARMA  ZIM LABORATORIES  SANJIVANI PA  BLISS GVS PHARMA  WOCKHARDT  

Compare AUROBINDO PHARMA With:   ANUH PHARMA  ZIM LABORATORIES  SANJIVANI PA  BLISS GVS PHARMA  WOCKHARDT  




Today's Market

Telecom Companies' Subscriber Data, Jubilant FoodWorks Quarterly Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed heavy selling during the second-half yesterday and ended lower.

Views on news

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS